Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 10, 2006

DSM Biologics Provides Manufacturing Services to Argenes

  • DSM Biologics and Argenes signed a biopharmaceutical manufacturing agreement. Under the terms of the agreement, DSM Biologics will provide Argenes with full process development services, analytical development services, and manufacturing batches for Argenes’ Anti-Fas IgM Mab.

    Argenes’ Anti-FAS IgM Mab is being developed as an antirheumatic agent. The services will be provided out of DSM Biologics’ manufacturing facility in Groningen, The Netherlands.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »